Silo Pharma, Inc.
SILO
$2.15
-$0.13-5.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.85% | -59.70% | 49.06% | -19.55% | -29.24% |
| Total Depreciation and Amortization | 16.00% | -6.45% | -6.45% | -6.45% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.88% | 30,531.03% | -- | -- | 1,169.23% |
| Change in Net Operating Assets | 107.11% | 90.00% | -107.27% | 1.09% | -150.28% |
| Cash from Operations | 39.17% | 49.85% | 14.94% | 29.04% | -75.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.74% | -102.71% | -1,279.31% | -136.39% | -59.33% |
| Cash from Investing | -52.74% | -102.71% | -1,279.31% | -136.39% | -59.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -63.54% | 25.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -101.29% | -- | -- | -63.54% | 29.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.26% | -10.05% | 187.02% | -217.32% | -34.89% |